NEW YORK ( TheStreet) -- CHANGE IN RATINGSAcadia Healthcare ( ACHC) was initiated with a buy rating at Cantor Fitzgerald. $35 price target. Company should benefit from a better regulatory environment and can deliver above-average growth, Cantor Fitzgerald said. Affiliated Managers ( AMG) was upgraded at Goldman to buy. Company can generate solid organic growth, Goldman said. $170 price target. Carnival ( CCL) was downgraded to hold at TheStreet Ratings. Coach ( COH) was upgraded to buy from neutral at Citigroup. The stock has transitioned to a value stock and the risk is partially priced in, Citi said. Price target remains $56. Cash America International ( CSH) was downgraded at Sterne Agee to neutral. Valuation is full. The stock is up 33% year-to-date and within 4% of Stern Agee's new price target of $55. Discover ( DFS) was upgraded at FBR Capital Markets to outperform from market perform. $48 price target. Estimates also boosted, given higher receivables and interest income, as well as lower credit costs, FBR Capital Markets said. Dril-Quip ( DRQ) was initiated with a buy rating at Lazard Capital Markets. $105 price target. Company can deliver 25% annual earnings growth over the next two years. First Cash Financial Services ( FCFS) was downgraded at Sterne Agee to neutral. The call is based on a fair valuation, Sterne Agee said. Fortress ( FIG) was upgraded at Goldman Sachs to buy. Legacy funds have recovered well, Goldman said. Freescale ( FSL) was downgraded at Bernstein Research to market perform from outperform. Valuation call, based on an $18 price target, Bernstein said. Genesco ( GCO) was upgraded at Piper Jaffray to overweight from neutral. $73 price target. Company has strong long-term earnings potential, Piper Jaffray said. Hasbro ( HAS) was downgraded at Keybanc to hold from buy. The stock has doubled the market year-to-date and the company lacks near-term catalysts, Keybanc said. Oracle ( ORCL) was upgraded at Canaccord Genuity to buy from hold. $42 price target. Stock sets up well for a 10%-20% run, Canaccord Genuity said. Stericycle ( SRCL) was initiated with a buy rating at Goldman Sachs. $115 price target. Company can continue to gain domestic market share and also grow outside of the U.S., Goldman said.